is essential for renal proximal tubule reabsorption and accumulation of transcobalamin-B12. Am J Physiol Renal Physiol 282: F408-F416, 2002; 10.1152/ajprenal.00206.2000.-Megalin has previously been shown to bind and mediate endocytosis of transcobalamin (TC)-B12. However, the physiological significance of this has not been established, and other TC-B12 binding proteins have been suggested to mediate renal uptake of this vitamin complex. The present study demonstrates by the use of megalin-deficient mice that megalin is, in fact, essential for the normal renal reabsorption of TCvitamin B 12 and for renal accumulation of this highly conserved vitamin. Megalin-deficient mice excrete increased amounts of TC and B 12 in the urine, revealing a defective renal tubular uptake of TC-B 12. The urinary B12 excretion is increased ϳ4-fold, resulting in an ϳ28-fold higher renal B 12 clearance. This is associated with an ϳ4-fold decrease in B12 content in megalin-deficient kidney cortex. Thus megalin is important to prevent urinary loss of vitamin B 12. In addition, light-and electron-microscopic immunocytochemistry demonstrate lysosomal accumulation of B 12 in rat and mouse proximal tubules. In rats this accumulation is correlated with vitamin intake. Thus renal lysosomal B 12 accumulation is dependent on vitamin status, indicating a possible reserve function of this organelle in the rat kidney.
VITAMIN B 12 SERVES AS AN ESSENTIAL cofactor for important mammalian enzymes, including the cytoplasmic enzyme methionine synthetase and the mitochondrial enzyme methylmalonyl-CoA mutase. Vitamin deficiency is associated with severe hematological and neurological defects. Vitamin B 12 supplied with food is bound to intrinsic factor and absorbed in the intestine by a process involving the receptor cubilin (1, 26, 40) . Absorbed B 12 bound to transcobalamin C (TC) is transported to the tissues. The TC-B 12 complex (mol mass ϳ50 kDa) is filtered in the glomeruli. This is followed by tubular reabsorption to prevent urinary losses of this highly conserved vitamin (25) . The rat kidney accumulates large amounts of vitamin B 12 (2, 15, 17, 23, 32, 39) , concentrated in the proximal tubules (38) . Membrane fractionation studies in rat kidneys have suggested accumulation of vitamin B 12 in lysosomalenriched fractions, although no morphological support has been provided (27, 28) .
Two receptors for the renal tubular uptake of TC-B 12 have been reported: the multiligand, endocytic receptor megalin (25) and a 62-kDa protein of yet unknown structure localized by immunoblotting to kidney cortical membranes (4, 5) . Megalin (600 kDa) belongs to the low-density lipoprotein receptor family (36) . It is expressed in kidney proximal tubules (7, 9, 19, 20, 24, 33) and several other absorptive epithelia (reviewed in Refs. 6 and 13). Megalin is able to bind and mediate the endocytosis of TC-B 12 (25) . Whereas megalin is expressed in the apical endocytic apparatus facing the ultrafiltrate, the 62-kDa protein apparently is expressed mainly in the basolateral membranes (4) . The significance of these receptors for the renal uptake of TC-B 12 has not been clarified so far.
To examine the importance of megalin to renal B 12 uptake and vitamin status in vivo, we analyzed the uptake of TC-B 12 and vitamin B 12 accumulation in megalin-deficient mice. The data show megalin deficiency to be associated with increased urinary excretion of TC and B 12 as well as decreased renal B 12 accumulation. We also investigated renal accumulation of vitamin B 12 in proximal tubule cells from rats subjected to different levels of vitamin intake. In conclusion, megalin-mediated TC-B 12 uptake is essential to prevent urinary loss of the vitamin and to maintain normal renal B 12 status. Furthermore, renal accumulation of B 12 in rat proximal tubule lysosomes is dependent on the vitamin status, indicating a possible reserve function of this organelle in the kidney.
MATERIALS AND METHODS
Tissues and urine samples. Megalin-deficient mice were produced by gene targeting as described in Willnow et al. (44) . Sex-matched wild-type and heterozygous littermates were used as controls. Mice were kept on a normal diet (0.08 mg vitamin B 12/kg food) with free access to drinking water. Urine was collected during a 16-h period from mice aged 10-16 wk. Collections were performed simultaneously from megalin-deficient and sex-matched wild-type littermates. Urine was kept on ice during the sampling period to minimize protein degradation. For determination of vitamin B12 concentration, the kidney cortices were removed from anesthetized mice and immediately frozen. For immunocytochemistry, mouse kidneys were fixed by perfusion of 4% paraformaldehyde in 0.1 M cacodylate buffer, pH ϭ 7.4, through the left ventricle of the heart.
Newly weened male Wistar rats were kept on a normal (0.041 mg/kg food; Altromin, Lage, Germany) or low-vitamin-B12 (0.011 mg/kg food; Altromin) diet for 60 days. Vitamin B12-overloaded rats were fed a normal diet for 60 days and injected subcutaneously with cyanocobalamine (10 g/day; SAD) for 17 days before death. All rats were at the same age when killed. The left renal vessels were ligated, and the kidney was removed and frozen for analysis of vitamin B12. The liver, intestines, and right kidney were fixed by retrograde perfusion with 4% paraformaldehyde in 0.1 M cacodylate buffer, pH ϭ 7.4, through the abdominal aorta. Random urine specimens were collected from three male patients suffering from Dent's disease, as well as from three control subjects, and frozen until processed for immunoblotting. All patients had clinical and laboratory features of the disease and a serum creatinine level Ͻ200 mol/l.
Antibodies. A monoclonal anti-B12 antibody (ascites; Sigma) and a polyclonal sheep anti-B12 antibody (Biogenesis) were used to identify B12 by immunocytochemistry. The affinity of the monoclonal anti-B12 antibody for different cobalamin forms [cyanocobalamin (Sigma), hydroxycobalamin (Gea), methylcobalamin (Sigma), 5Ј-deoxyadenosylcobalamin (Sigma), and dicyanocobinamide (Sigma)] was analyzed by their ability to displace 57 Co-cyanocobalamin (0.39 MBq/ml; Amersham) from the monoclonal anti-B12. One hundred microliters of the anti-B12 antibody diluted 1:1,000 with 0.1 M PBS and 0.1% human albumin (ORHA 20/21; Aventis Behring) were incubated with 100 l of each of the cobalamins (412-1,000 nM) and 50 l of 57 Co-cyanocobalamin. After 20 h of incubation at 4°C, free and bound cobalamin were separated using hemoglobin (Difco)-coated charcoal (Sigma). Bound 57 Co-cyanocobalamin was counted in a Wallac 1480 gamma counter. The analyses showed that hydroxycobalamin, methylcobalamin, and cyanocobalamin were able to displace labeled cyanocobalamin from the monoclonal antibody, whereas 5Ј-deoxyadenosylcobalamin and dicyanocobinamide were unable to displace cyanocobalamin from the antibody (Fig. 1) .
Polyclonal anti-rabbit TC antibody was produced by immunization of a guinea pig by five consecutive injections totaling 0.5 mg of rabbit TC purified from rabbit serum (29) . Polyclonal anti-human TC was raised against recombinant human TC. For double-labeling experiments to identify lysosomal structures, we used polyclonal rabbit anti-rat LAMP-1 (kindly provided by Dr. Ira Mellman) or anti-rat cathepsin B (Upstate Biotechnology). The following secondary antibodies were used: horseradish peroxidase (HRP)-conjugated rabbit anti-guinea pig, goat anti-rabbit, goat anti-mouse, or rabbit anti-sheep IgG (DAKO), FITC-conjugated goat anti-mouse IgG (DAKO), rhodamine-conjugated swine anti-rabbit IgG (DAKO), gold-conjugated goat anti-mouse, and goat antirabbit IgG (British BioCell).
Determination of vitamin B12 concentration in serum, urine, and renal tissues. Between 17 and 41 mg kidney cortex was homogenized in 0.4 ml of 10 mM PIPES buffer containing (in mM) 1 EGTA, 3 MgCl 2, 0.4 NaCl, and 1 PMSF, pH 7.4, followed by centrifugation at 20,000 g for 40 min at 4°C. The total amount of B 12 in the supernatant, serum, and urine was analyzed by an automated protein binding assay (ACS 180 Plus; CHIRON/Diagnostics). Unsaturated serum B 12 binding capacity was determined as described in Gottlieb et al. (14) . Creatinine and urea in mouse serum were measured using automatic equipment (Cobas-Integra; Hoffmann-La Roche).
SDS-PAGE and immunoblotting of urine samples. Urine samples were concentrated using Centricon YM-10 centrifugal filter devices (Millipore) and mixed with Laemmli sample buffer containing 2.5% SDS and subjected to SDS-PAGE using polyacrylamide minigels (Bio-Rad Mini Protean II). The gels were transferred to nitrocellulose paper. Blots were blocked with 5% milk in PBS-T (80 mM Na 2HPO4, 20 mM NaH2PO4, 100 mM NaCl, 0.1% Tween 20, pH 7.5) for 1 h and incubated overnight at 4°C with anti-TC antibody in PBS-T with 1% BSA. After being washed in PBS-T, the blots were incubated for 1 h with HRP-conjugated anti-guinea pig or anti-rabbit IgG. After the final wash, antibody binding was visualized by using an enhanced chemiluminescence system (Amersham). Controls involving incubation without primary antibody and incubation with preimmune serum revealed no significant labeling.
Immunocytochemistry on renal tissue. Blocks of all perfusion-fixed tissues were postfixed in the same fixative for 2 h. For ultra-and semithin cryosections, tissue was infiltrated for 30 min in 2.3 M sucrose containing 2% paraformaldehyde and rapidly frozen in liquid N 2. For cryostat sections, tissue was infiltrated in 30% sucrose in 150 mM Sørensen's buffer (123 mM Na 2HPO4, 27 mM KH2PO4) and rapidly frozen using CO2. For light-microscopic immunocytochemistry, cryostat (10-15 m) or semithin cryosections (ϳ1 m) were cut on a Walter Dittes Kryostat or Reichert Ultracut S and placed on coated glass slides. Cryostat sections were heated, dehydrated/rehydrated in graded alcohols, and permeabilized with 0.05% saponin before incubation with the primary antibody. Sections were incubated with a primary anti-B 12 antibody in 0.01 M PBS, 0.15 M NaCl, 0.1% skim milk, and 0.02 M NaN 3, followed by incubation with florescent or HRPlabeled anti-mouse, anti-rabbit, or anti-sheep IgG. Peroxidase labeling was visualized by incubation with diaminobenzidine and 0.03% H 2O2 for 10 min. For double labeling, both mouse anti-B12 and rabbit anti-cathepsin B antibodies were applied, followed by conjugated anti-mouse and anti-rabbit IgG. All incubations were performed at room temperature, and sections were counterstained with Meiers hematoxylin before examination in a Leica DMR microscope equipped with a Sony SCCD color video camera or a Zeiss LSM510 laser confocal microscope. Electron-microscopic immunocytochemistry was performed on 90-nm cryosections incubated overnight at 5°C with anti-B 12 (IgG concentration: 450 g/ ml), followed by incubation with gold-conjugated anti-mouse IgG secondary antibody in 0.05 M Tris buffer, 0.15 M NaCl, 0.1% BSA, 0.06% polyethylene glycol, 1% fish gelatin, and 0.02% NaN 3 for 2 h at room temperature. For double-labeling experiments, sections were incubated with anti-B12 and anti-LAMP-1 (1:8,000) followed by incubation with gold-conjugated anti-mouse (10 nm) and anti-rabbit (5 nm) secondary antibodies. Controls involving incubation without primary antibody and incubation with preimmune serum, nonspecific rabbit serum, or mouse IgG 1 revealed no significant labeling. 12 and accumulation of the vitamin. In megalindeficient mice, increased urinary excretion of both TC ( Fig. 2 ) and vitamin B 12 (Table 1 ) was observed. Urinary B 12 concentration was increased approximately fourfold despite significant lower serum B 12 levels. As a result, urinary B 12 clearance was increased ϳ28-fold in megalin-deficient mice. Furthermore, no vitamin B 12 could be identified by immunocytochemistry in the proximal tubules from megalin-knockout mice, indicating defective cellular uptake of the vitamin (Fig. 3) . Little or no TC was identified in urine from control littermates (Fig. 2) , whereas cellular B 12 uptake was evident in proximal tubules (Fig. 3) . The defect in vitamin accumulation in megalin-deficient mice was further substantiated by the determination of vitamin B 12 concentration in kidney cortical tissue from two megalin-knockout mice, showing a fourfold reduction compared with normal controls (Table 1) .
RESULTS

Megalin is important for normal uptake of filtered TC-B
Although there was no significant difference in urinary output or in urinary creatinine or urea excretion between megalin-deficient and wild-type or heterozygous mice (Table 1) , a reduction in urea clearance was calculated in megalin-deficient mice, indicating reduced filtration in these animals.
TC-B 12 is normally filtered and reabsorbed in the human kidney. The possibility of tubular reabsorption of filtered TC in humans was investigated by analyzing urine from the patients with Dent's disease. This Fanconi-like syndrome, caused by mutations in the renal chloride channel ClC-5 (41) , is characterized by tubular proteinuria, hypercalciuria, nephrolithiasis, and, possibly, a decrease in proximal tubule megalin expression (34) . In analyzed urine samples from all three patients, TC could be clearly identified by immunoblotting, whereas only traces of TC were observed in urine from control subjects (Fig. 4) . This shows that excretion of TC in human urine is strongly increased when tubular reabsorption is defective, indicating that glomerular filtration of TC-B 12 is followed by efficient reabsorption in a normal human kidney.
Internalized B 12 accumulates in lysosomes. Immunocytochemistry in normal mouse and rat kidneys using a monoclonal antibody against vitamin B 12 showed distinct intracellular labeling concentrated in vesicular structures (Figs. 3a and 5a ). No vesicular labeling was observed outside the proximal tubule, although a weak and diffuse cytoplasmic staining of other cell types, including the distal tubules, could be observed at high concentrations of the primary antibody (not shown). Preincubating the antibody with cyano-or hydroxycobalamin at a concentration 50 times higher than that of the primary antibody (ϳ3 pM) totally inhibited labeling (inset, Fig. 5a ), whereas attempting to convert all forms of B 12 to cyanocobalamin by pretreating sections with 32 M KCN in acetate buffer did not affect labeling (not shown). Electron microscopy confirmed the immunohistochemical findings, showing a heavy labeling for vitamin B 12 in electron-dense structures in selected segment 1 proximal tubules (Fig. 5b) . In addition, labeling was seen in the mitochondria of all tubular cells, including distal tubules (not shown). Some gold particles were identified in the endocytic apparatus and cytoplasm of the proximal tubules. Doublelabeling immunocytochemistry, showing colocalization of vitamin B 12 and the lysosomal membrane protein LAMP-1, confirmed the very intense labeling for the vitamin in some, but not all, lysosomes in the first part of the proximal tubules (Fig. 5b) . The vesicular labeling in normal mouse proximal tubules (Fig. 3a) is more apically located than in rat tubules (Fig. 5a) , suggesting a more apical localization of B 12 -containing endosomes/lysosomes in mice compared with rats. This is confirmed by doubling labeling in normal mice and rats (not shown), demonstrating colocalization of the lysosomal enzyme cathepsin B and B 12 in vesicular structures located similarly to the B 12 labeling in Fig. 3a (mouse) and 5a (rat), respectively.
Lysosomal accumulation of B 12 depends on vitamin intake. Feeding rats with a low-vitamin B 12 diet caused an ϳ30-fold reduction in renal vitamin content as well as a reduction in serum B 12 , in combination with increased unsaturated serum B 12 binding capacity (Table 2). Conversely, daily injections of cyanocobalamin increased renal vitamin concentration approximately twofold in combination with increased serum B 12 and decreased unsaturated serum B 12 binding capacity ( Table 2 ). Thus changes in vitamin intake are reflected in changes in renal B 12 accumulation. Immunocytochemistry revealed dose-dependent labeling for vitamin B 12 in kidney proximal tubules (Fig. 6) . In vitamin-deprived rats, hardly any vitamin labeling could be observed (Fig. 6a) , whereas, in rats fed a normal diet, vesicular labeling is evident in proximal tubules (Fig. 6b) . In vitamin-loaded rats, more intense labeling is seen (Fig. 6c) . Double-labeling immunocytochemistry identifying vitamin B 12 and the lysosomal enzyme cathepsin B showed that the B 12 labeling in rats loaded by vitamin injection colocalized with lysosomal label- Values are means Ϯ SE except for kidney B12 concentration; ND, not determined. a P ϭ 0.0003 (ANOVA); b P ϭ 0.00001 (ANOVA); c P ϭ 0.0009 (t-test);
d P ϭ 0.000008 (t-test); e P ϭ 0.04 (t-test); f P ϭ 0.012 (t-test) for differences between groups.
ing ( Fig. 6d) , suggesting that the vitamin under conditions of vitamin surplus accumulates in proximal tubule lysosomes. No vitamin B 12 labeling was observed at the light-microscopic level in the ileal epithelial cells or in the liver cells of vitamin-loaded or -deprived rats (not shown).
DISCUSSION
The data presented show that megalin is important for the renal tubular uptake and accumulation of vitamin B 12 . The present gene-knockout data are substantiated by previous studies showing that megalin binds TC-B 12 with high affinity and is able to mediate the endocytosis and cellular uptake of this complex (25) . Whereas the previous study did not examine the physiological significance of this mechanism, the present study demonstrates that megalin deficiency is associated with increased urinary excretion of vitamin B 12 and its carrier protein TC and with a decreased accumulation of vitamin in the renal proximal tubules. The present data, combined with the strong apical expression of megalin in the proximal tubule, support an essential function of megalin to prevent urinary loss of this highly conserved vitamin.
Vitamin B 12 is absorbed in the intestines bound to intrinsic factor. The intrinsic factor-vitamin B 12 receptor cubilin is a 460-kDa peripheral membrane protein with no obvious transmembrane domain (26) . Cubilin may be internalized after binding to megalin (26) . Thus, although cubilin is expressed in megalin-deficient mice, it may be functionally impaired, affecting the intestinal absorption of vitamin B 12 . Although this may contribute to the observed reduction in serum B 12 Values are means Ϯ SE; n ϭ 3 rats/group. Rats were fed a low-or normal-vitamin B12 diet for 60 days. Rats loaded with vitamin B12 were injected subcutaneously with cyanocobalamin for 17 days. levels, it does not affect renal handling of B 12 . The finding of an approximately fourfold increase in urinary excretion of B 12 in megalin-deficient mice, reflecting a Ͼ20-fold increase in B 12 clearance, is important. This establishes defective tubular uptake and shows that the decrease in renal accumulation of TC and B 12 is not due to the reduced plasma vitamin levels or decreased filtration of the vitamin, as these would both result in a decrease in urinary vitamin excretion. Very little, if any, intrinsic factor is present in serum or urine and, whereas megalin binds TC-B 12 strongly [dissociation constant (K d ), ϳ180 nM; 25], the binding of this complex to cubilin is very weak and not strong enough to allow any estimation of K d when analyzed by surface plasmon analysis (data not shown).
Megalin is also expressed in other absorptive epithelia, including enterocytes (1), ependyma (45), yolk sac (11, 22, 35) , and possibly placental syncytiotrophoblast cells (45) and thus may be involved in the transport of vitamin B 12 to other, especially fetal, tissues.
In addition to megalin, a 62-kDa (normally present as a 124-kDa dimer) TC-B 12 binding protein has been identified in the kidney, placenta, intestines, and liver (3) (4) (5) . However, in contrast to megalin, this 62-kDa protein of still unknown structure is preferentially expressed in basolateral membranes of renal cells when analyzed by membrane fractionation (4). On the basis of the present data, we suggest that megalin is important for the luminal uptake of filtered TC-B 12 and for the renal accumulation of B 12 . Other proximal tubule TC-B 12 binding proteins may possibly be involved in basolateral uptake or secretion as well as in intracellular transport.
Dent's disease is a Fanconi-like renal tubular defect caused by mutations in the renal chloride channel ClC-5 (41). It is characterized by hypercalciuric nephrolithiasis and low-molecular-weight proteinuria similar to that observed in megalin-deficient mice (21) . The increased excretion of TC in urine from patients suffering from this tubular defect compared with normal human subjects indicates that TC-B 12 is filtered in the human glomeruli but normally reabsorbed, suggesting that renal tubular luminal uptake in humans may prevent loss of the vitamin in urine. This is also consistent with previous suggestions that an endocytic dysfunction may underlie the tubular proteinuria of this disease (10, 16, 43) . Recently, it has been shown that ClC-5 disruption impairs proximal tubule endocytosis and causes a reduction in proximal tubule luminal expression of megalin (34) , indicating a functional relationship between ClC-5 and megalin-mediated endocytosis. Also, in a rat model of autosomal-dominant polycystic kidney disease, tubular proteinuria is associated with decreased endocytic activity in cyst-lining epithelial cells colocalizing with defective expression of both ClC-5 and megalin (31) . Traces of TC were identified by immunoblotting in urine from normal human subjects but not in normal mouse urine. This is most likely due to the use of two different anti-TC antibodies. A rabbit anti-recombinant human TC antibody is used to identify human TC, whereas a guinea pig anti-rabbit TC is used to identify mouse TC. The affinity of anti-human TC for human TC is likely to be higher than the affinity of anti-rabbit TC for mouse TC, explaining why TC is detected in human urine only.
Most megalin-deficient mice die perinatally (44); however, ϳ1 of 50 survive to adulthood, forming the basis for the present study. The kidneys of these mice are generally normal. Ultrastructurally, the glomeruli are normal, whereas the proximal tubule cells reveal a loss of endocytic invaginations, vesicles, and dense apical tubules, which supports decreased endocytic activity (21) . An ϳ40% reduction in urea clearance is observed in megalin-deficient mice, which, for the first time, estimates renal function in these animals. The reason for this is unknown. Although megalin has been localized in the glomeruli of rats, it has not been identified in other species, including mice. There is no evidence of changes in the glomerular ultrastructure or in the filtration of proteins, and, in particular, there is no suggestion of glomerular proteinuria in megalindeficient mice (8, 21, 30) . Megalin is a multiligand receptor that is important for the tubular reabsorption of other vitamin-carrier protein complexes, including retinol-binding protein (8) and vitamin D-binding protein-vitamin D (30) . Thus megalin appears to serve a specific and important vitamin-scavenger-receptor function that prevents excessive urinary loss of filtered, protein-bound vitamins.
Vitamin B 12 identified by immunohistochemistry accumulates in the lysosomes of rat kidney proximal tubules, and this accumulation is dependent on the vitamin status of the animal. The lysosomal accumulation in cryostat sections appears to be concentrated in the first part of the proximal tubule, indicating an efficient tubular uptake of filtered TC-B 12 . This is in accordance with the high-affinity binding of TC-B 12 to megalin (25) . Lysosomal accumulation of B 12 in the rat kidney supports previous studies based on tissue fractionation by gradient centrifugation (27, 28) .These studies showed that the concentration of endogenous cobalamin in kidney lysosomes is five to six times that of mitochondria (27) . Variations in cobalamin supply are associated with extensive changes in rat kidney vitamin accumulation, confirming the results of previous studies (15, 37, 39) . Animals loaded with vitamin B 12 in the present study exhibited a 60-fold increase in renal vitamin accumulation compared with vitamindepleted animals. This is associated with a similar change in the immunolabeling for vitamin B 12 in the renal proximal tubules. When animals are loaded with cobalamin, increased labeling of lysosomes in the proximal tubule is observed. In contrast, rats fed on a low-vitamin diet revealed no immunodetectable vitamin in the proximal tubule lysosomes by light microscopy. Interestingly, no labeling was observed at the light-microscopic level in the intestinal epithelial cells or in the liver of vitamin-loaded rats, suggesting the immunodetectable lysosomal accumulation to be characteristic of the kidney proximal tubule cells.
The conceivable vitamin-conserving function of the proximal tubule implies that the reabsorbed and stored vitamin B 12 eventually is returned to the circulation. The mechanism for this process is not resolved; however, in light of our present data, this must involve release of the vitamin from the lysosomal compartment. A specific transport system for vitamin B 12 has been identified in rat liver lysosomal membrane vesicles, suggesting that the vitamin initially is transported into the cytoplasm (18) . Also, an unusually large lysosomal accumulation of vitamin B 12 has been demonstrated in fibroblasts from patients suffering from cblF disease. This is an inborn error of cobalamin metabolism, characterized by a defective transfer of the vitamin to target enzymes (42) . These data indicate the presence of a specific mechanism for the release of vitamin B 12 from lysosomes. Further cellular processing of vitamin B 12 requires secretion at the basolateral membranes in complex with carrier proteins or as free B 12 , which is then complexed extracellularly. Whether the vitamin is metabolized by transformation into different cobalamin derivatives within the proximal tubule cell has not been established. At the electron-microscopic level, vitamin B 12 labeling was observed both in the mitochondria and, to a lesser extent, in the cytoplasm of all cell types analyzed, including intestinal epithelial cells and liver cells. This labeling corresponds to the known localization of the vitamin B 12 -dependent enzymes. Binding competition analysis of the monoclonal anti-B 12 antibody used in this study suggested that the antibody reacted with equal affinity for cyanocobalamin, hydroxycobalamin, and methylcobalamin but with significantly less affinity for 5Ј-deoxyadenosylcobalamin. All forms of vitamin B 12 are found in tissue extracts, but the major part of 5Ј-deoxyadenosylcobalamin is localized in the mitochondria. Both methyl-and 5Ј-deoxyadenosylcobalamin are converted to hydroxycobalamin on exposure to light and, with addition of cyanide, hydroxycobalamin is converted to cyanocobalamin. It is unlikely that any free 5Ј-deoxyadenosylcobalamin remains stable in thin cryosections heavily exposed to light for 1-2 h before immunolabeling. This implies that any possible in vivo changes in the relative distribution of various cobalamin forms would not influence labeling intensity. This hypothesis is supported by the finding that preincubation of sections with KCN did not affect labeling intensity of kidney proximal tubule cells.
In conclusion, the present study establishes the importance of megalin in renal tubular luminal reabsorption of TC-B 12 and vitamin accumulation, emphasizing its role as a vitamin-carrier protein-scavenger receptor. Our studies in Dent's disease implicate proximal tubular function in humans as necessary for physiological TC-B 12 reabsorption from the glomerular filtrate. Also, in rat proximal tubules, a vitamin intake-dependent lysosomal accumulation of vitamin is observed, suggesting that this organelle may serve a reserve function in the rat kidney. Whether this function is quantitatively important and actively regulated, possibly by regulated release from the kidney, remains to be elucidated.
